WO2008018147A1 - Fat or oil composition - Google Patents
Fat or oil composition Download PDFInfo
- Publication number
- WO2008018147A1 WO2008018147A1 PCT/JP2006/315925 JP2006315925W WO2008018147A1 WO 2008018147 A1 WO2008018147 A1 WO 2008018147A1 JP 2006315925 W JP2006315925 W JP 2006315925W WO 2008018147 A1 WO2008018147 A1 WO 2008018147A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- fat
- fatty acid
- content
- fats
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/02—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fatty acids with glycerol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
- A23D9/013—Other fatty acid esters, e.g. phosphatides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B5/00—Preserving by using additives, e.g. anti-oxidants
- C11B5/0021—Preserving by using additives, e.g. anti-oxidants containing oxygen
- C11B5/0035—Phenols; Their halogenated and aminated derivates, their salts, their esters with carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
- C11C3/06—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with glycerol
Definitions
- the present invention relates to an oil and fat composition having a high diacylglycerol content containing conjugated linoleic acid.
- diacylglycerol has also been found to have an anti-obesity effect and the like (Patent Documents 7 and 8). Furthermore, fats and oils containing diacylglycerol having a high content of specific fatty acids such as ⁇ 3 fatty acids and linoleic acid are known (Patent Documents 9 to 11).
- Patent Document 12 an oil and fat composition combining diacylglycerol and plant sterol has been found to have an effect of improving blood cholesterol level.
- Conjugated linoleic acid is a free fatty acid, so it was not suitable for ingestion or use in foods due to the unique taste of fatty acids.
- Patent Documents 13 to 18 conjugated linoleic acid into an ester form
- Non-Patent Documents 2 and 3 Non-Patent Documents 2 and 3
- Patent Document 1 International Publication No. 96 ⁇ 06605 Pamphlet
- Patent Document 2 Pamphlet of International Publication No. 97 ⁇ 46230
- Patent Document 3 Japanese Patent Laid-Open No. 2003-171272
- Patent Document 4 Pamphlet of International Publication No. 02Z009691
- Patent Document 5 Pamphlet of International Publication No. 02 ⁇ 009693
- Patent Document 6 International Publication No.OOZ21379 Pamphlet
- Patent Document 7 Japanese Patent Laid-Open No. 4-300826
- Patent Document 8 JP-A-10-176181
- Patent Document 9 Pamphlet of International Publication No. 01Z109899
- Patent Document 10 International Publication No. 02Z11552 Pamphlet
- Patent Document 11 European Publication No. 0679712
- Patent Document 12 Pamphlet of International Publication No. 99Z48378
- Patent Document 13 International Publication No. 00Z64854 Pamphlet
- Patent Document 14 International Publication No.04Z96748 Pamphlet
- Patent Document 15 Japanese Patent Application Laid-Open No. 2003-113396
- Patent Document 16 US Patent No. 6432453
- Patent Document 17 US Patent No. 6608222
- Patent Document 18 European Patent Publication No. 1097708
- Non-Patent Document 1 "Lipids”, 1997, 32 ⁇ , p. 853-858
- Non-Patent Document 2 "Biotechnology Letters", 1998, 20 ⁇ , No. 6, p. 617-621
- Non-Patent Document 3 "Biotechnol. Prog., 2004, 20 ⁇ , p. 619-622
- the present invention provides the following components (A) and (B):
- A 15% by weight of diacylglycerol having an unsaturated fatty acid content of 80% by weight or more, a conjugated linoleic acid content of 2 to 92% by weight, and an ⁇ 3 unsaturated fatty acid content of less than 15% by weight
- the mono-acylglycerol content is 5% by weight or less
- the free fatty acid content is 5% by weight or less
- the weight ratio of 1,3-diacylglycerol Z1,2-diacylglycerol is 1-5.
- the oil-and-fat composition containing this is provided.
- an object of the present invention is to provide a high diacylglycerol content oil / fat composition containing conjugated linoleic acid having a remarkable anti-obesity effect and excellent stability, The object is to significantly improve the storage stability of the oil and fat composition.
- the present inventors can solve the above problems by adjusting the diacylglycerol content, the conjugated linoleic acid content, the tocopherol content, etc. in the diacylglycerol to a specific range. I found. Furthermore, they have found that the obtained oil and fat composition has an anti-feeding effect, leading to the present invention. In addition, it was found that the preservability at low temperature of the obtained oil and fat composition was improved.
- the oil and fat composition of the present invention contains the oil and fat of component (A) as an essential component.
- the fat (A) contains 15% by weight (hereinafter simply referred to as “%”) of diacylglycerol (hereinafter also simply referred to as “DAG”), preferably 15 to 95%. More preferably 20 to 95%, further 35 to 95%, especially 60 to 90%, especially 70 to 85%, physiological effects, industrial productivity of fats and oils, appearance, food application, etc. Is preferable.
- diacylglycerol contained in the oil and fat (A) is a force in which 80 to LOO% of the constituent fatty acid is an unsaturated fatty acid, preferably 85 to LOO%. Further, 90 to 98%, particularly 93 to 98% is preferable from the viewpoint of appearance, physiological effect, and industrial productivity of fats and oils.
- the carbon number of the unsaturated fatty acid is preferably 14 to 24, and more preferably 16 to 22.
- CLA conjugated linoleic acid
- 2-92 0/0 which force preferably ⁇ or 5-80 0/0, further 15 to 70 0/0, especially 20-60 0/0, it is body fat reduction is especially 25-50%, eating It is preferable in terms of suppression, storage stability, appearance, and fatty acid intake balance.
- Examples of the conjugated linoleic acid include 9,11-octadecadienoic acid, 10,12-octadecadienoic acid, their positions and geometric isomers, and mixtures thereof. Specific examples include cis-9, trans-11-octadecadienoic acid, trans-9, cis-11-octadecadienoic acid, trans-10, cis-12-octadecadienoic acid, and the like.
- Conjugated linoleic acid is produced by, for example, using linoleic acid or oils with high linoleic acid content as raw materials, biochemical conjugation using ruminant or microbial enzymes, and chemical treatment by heating under alkaline conditions.
- the content of oleic acid is 1 to 65% among the fatty acids constituting diacylglycerol contained in the fat (A). Power of -50%, especially 5-40%, especially 10-30% is preferred in terms of storage stability, appearance, and fatty acid intake balance. Furthermore, from the viewpoints of appearance and physiological effects, the content of dioleylglycerol in diacylglycerol is preferably less than 45%, particularly preferably 0 to 40%! /.
- the content of the ⁇ 3-unsaturated fatty acid is less than 15%. % Is preferable in terms of stability, appearance, and fatty acid intake balance.
- the ⁇ 3 unsaturated fatty acid include a linolenic acid, eicosapentaenoic acid, docosahexaenoic acid, and the like.
- the content of saturated fatty acids is less than 20%, preferably 0 to 10%, more preferably 1 to 7%, especially 2 to 7%, particularly 2 to 6%, is preferable in view of appearance, physiological effect, and oil and fat industrial productivity.
- Saturated fatty acids are more preferably palmitic acid and stearic acid, preferably those having 14 to 24 carbon atoms, particularly 16 to 22 carbon atoms.
- the content of trans-unsaturated fatty acids other than conjugated linoleic acid among the fatty acids constituting diacylglycerol contained in the fat (A) is 0 to 3.5%.
- 0.1 to 3% is preferred in terms of flavor, physiological effect, appearance, preservability, and industrial productivity of fats and oils.
- the content of fatty acids having 12 or less carbon atoms is 5% or less in terms of flavor. It is preferably 0 to 2%, more preferably 0 to 1%, particularly preferably substantially free.
- the remaining constituent fatty acids preferably have 14 to 24 carbon atoms, especially 16 to 22 carbon atoms.
- the proportion of 1,3 diacylglycerol (1,3-DAG) in diacylglycerol (DAG) contained in the fat (A) is preferably 50% or more. More preferably 52-: LOO%, further 54-90%, especially 56-80%. Preferable from the viewpoint of physiological effect, storage ability, industrial productivity of fats and oils, and flavor.
- DAG is composed of 1,3-DAG and 1,2-diacylglycerol (1,2-DAG).
- the weight ratio of 1,3-DAG / l, 2-DAG in fats and oils is 1-5.
- ⁇ 1 Preferably ⁇ 1.
- the power of 5 to 3.8, 2 to 3.5, especially 2.1 to 3.2 is preferable in terms of storage stability at low temperatures, physiological effects, and industrial productivity of fats and oils. .
- the fat ( ⁇ ) contains 4.9-84.9% triacylglycerol (hereinafter also simply referred to as “TAG”). -64. 9% and 6.
- the content of conjugated linoleic acid in the constituent fatty acids of triacylglycerol contained in the fat (A) is 50% or less, more preferably 1 to 35%, particularly
- the content of conjugated linoleic acid in the fatty acid constituting diacylglycerol contained in the fat (A) and the synergistic linole in the fatty acid constituting triacylglycerol is preferably 1 to 10, more preferably 2 to 9, especially 3 to 8, and especially 4 to 7 to improve storage stability and physiological effects. This is preferable.
- the content of oleic acid in the constituent fatty acid of triacylglycerol contained in the fat (A) is 15 to 70%, more preferably 20 to 65%, particularly 30 to 60%, especially 45 to 55%, is preferable from the viewpoint of storage stability, physiological effect, and industrial productivity of fats and oils.
- the constituent fatty acid of triacylglycerol contained in the fat (A) is preferably 80 to 100% of unsaturated fatty acid, more preferably 80 to 100%, and further 90 to 100%.
- 93 to 98%, especially 94 to 98% is preferable from the viewpoints of physiological effects and industrial productivity of fats and oils.
- the number of carbon atoms of the unsaturated fatty acid is preferably 10 to 24 and more preferably 16 to 22 in view of physiological effects and industrial productivity of fats and oils.
- the oil and fat (A) preferably has a power of 0.1 to 5% containing 5% or less of monoacylglycerol (hereinafter also simply referred to as “MAG”). 0 more 1 to 2%, further 0.1 to 1.5%, especially 0.1 to 1.3%, especially 0.2 to 1%. Flavor, appearance, fuming, industrial productivity of fats and oils, It is preferable in terms of application to foods and the like.
- MAG monoacylglycerol
- the constituent fatty acid of monoacylglycerol contained in the fat and oil (A) is the same constituent fatty acid as diacylglycerol. From the viewpoint of sex.
- the content of free fatty acid and Z or salt (hereinafter also simply referred to as "FFA") contained in the oil and fat (A) is 5% or less, but 0 to 3 5% is preferable, and further. ⁇ 2%, especially 0.01-1%, especially 0.05-0.5% Power S is preferred in terms of flavor, smoke, work comfort during cooking, and industrial productivity of fats and oils.
- the content of unsaturated fatty acid is preferably 80 to 100% of all fatty acids constituting the fat (A), and further 85 to 100%, particularly 90 to 100%. %,especially
- the content of fatty acids having 4 or more carbon-carbon double bonds is the oxidation stability, work comfort during cooking, physiological In terms of effect, coloring, flavor, etc., it is preferably 0 to 40%, arabic 0 to 20%, arabic 0 to 10%, in particular 0 to 1%, and substantially free! Is the most preferred.
- the content of trans-unsaturated fatty acid is 0 to 4% of the total fatty acids constituting the fat (A). Further 0.1 to 3.5% From the viewpoint of flavor, physiological effect, appearance, and industrial productivity of fats and oils.
- the content of trans-unsaturated fatty acid is determined by the AOCS method (American Oi).
- the content of conjugated linoleic acid is preferably 2 to 92% of all fatty acids constituting the fat (A).
- S is preferable, and further 5 to 65%, particularly 10 to 50%.
- % Especially 15 to 30%, is preferred in terms of physiological effects, storage stability, application to foods, etc., and industrial productivity of fats and oils.
- the content of oleic acid is preferably 20 to 65% of the total fatty acids constituting the fat (A).
- S is preferable, and further 25 to 60%, particularly 30 to 55%, Especially 35 ⁇ 5 It is preferably 0% in terms of storage stability, application to foods, etc., and industrial productivity of fats and oils.
- the content of linolenic acid is 15% or less of the total fatty acids constituting the fat (A). Further 0.1 to 12%, particularly 1 to 10% In particular, 2 to 8% is preferable in terms of storage stability, application to foods, industrial productivity of fats and oils, and physiological effects.
- the raw material for the fat (A) may be either vegetable or animal fat.
- the raw material include rapeseed oil, sunflower oil, corn oil, soybean oil, rice oil, safflower oil, cottonseed oil, and beef tallow.
- the oil and fat composition is composed of a mixture of these oils and fats, a hydrogenated or transesterified reaction and the like, and a fatty acid composition that is not hydrogenated. It is preferable to reduce the trans acid content in the total fatty acids.
- fats and oils used as the raw material for the fats and oils (A) deodorized oils and undeodorized fats and oils that have not been deodorized in advance can be used.
- the use of undeodorized fat or oil as part or all of the raw material reduces trans-unsaturated fatty acids other than conjugated linoleic acid, and the raw material fat or oil-derived plant sterol, plant sterol fatty acid ester, tocopherol , Because it can survive.
- the fat (A) includes the conjugated linoleic acid, the esterification reaction between the fatty acid derived from fat and glycerin and the ester exchange reaction between the fat and oil containing conjugated linoleic acid and glycerin, and the like.
- Excess monoacyl derrol produced by the reaction can be removed by molecular distillation or chromatography.
- These reactions can also be carried out by chemical reactions using an alkali catalyst or the like. However, it is desirable to carry out the reaction under mild conditions enzymatically using a 1,3-position selective lipase or the like in terms of flavor and the like. Excellent and preferred.
- the oil and fat composition of the present invention needs to contain the component Tocopherol.
- the content of tocopherol (B) is 0.001 to 2 parts per 100 parts by weight of fat (A) (hereinafter simply referred to as “parts”) in terms of flavor, oxidation stability, coloring, etc.
- the force is 0.005.
- a certain force S is preferable, more preferably 0.01 to 1 mm, particularly 0.01 to 0.5 mm, particularly 0.02 to 0.2 mm.
- ⁇ , ⁇ , ⁇ , ⁇ tocopherol or a mixture thereof can be used as the tocopherol (B).
- ⁇ -tocopherol from the viewpoint of acid / acid stability.
- the use of ⁇ -tocopherol is a flavor. It is preferable to prevent deterioration and off-flavor generation.
- Examples of commercially available tocopherols include imix D, imix 80 (Eisai Co., Ltd.), MDE-6000 (Yatsushiro Co., Ltd.), and E oil 400 (RIKEN vitamins Co., Ltd.). .
- the oil and fat composition may be supplemented with an antioxidant in addition to the tocopherol (B).
- Any antioxidant can be used as long as it is usually used in foods. Examples include butylhydroxytoluene (BHT), butylhydroxyl-sol (BHA), tertiary butylhydroquinone (TBHQ), catechin, vitamin C or its derivatives, phospholipids, rosemary extract, etc. Of these, it is preferable to use vitamin C or a derivative thereof, catechin, or rosemary extract, and it is particularly preferable to use a mixture of one or more of these.
- vitamin C or a derivative thereof a higher fatty acid ester of vitamin C that is soluble in fats and oils (A), for example, a fatty acid ester having an acyl group having 12 to 22 carbon atoms is more preferable.
- Ascorbic acid palmitate, L-ascorbic acid stearate is particularly preferred, and L-ascorbyl palmitate is most preferred!
- the content of vitamin C or a derivative thereof is 0.0004 to 0.1 part ascorbic acid with respect to 100 parts of fat (A).
- the oil and fat composition when the oil and fat composition is mixed with water or used in foods containing water, and when stored for a long time or in a light place, as an antioxidant.
- L-corcorbic acid fatty acid ester is substantially free from flavor deterioration and off-flavor generation
- the point power to prevent is also preferable.
- the oil and fat composition preferably contains the component (C) plant sterols.
- the plant sterols in the present specification also include those containing derivatives such as ester forms in which the hydroxyl group is not in a ester bond with a fatty acid but in a free state (free form).
- the content of the plant sterols (C) is preferably 0.05 to 30 parts, more preferably 0.3 to 20 parts, with respect to 100 parts of the fat (A). Further, 1 to 10 parts, especially 2 to 8 parts, especially 2.5 to 4. 7 parts, in terms of cholesterol lowering effect, flavor, appearance, storage at low temperature, and industrial productivity of fats and oils. preferable.
- a derivative such as an ester is included as the component (C)
- the content converted to the free form is defined as the content of the component (C).
- the plant sterols (C) also include plant stanols.
- Plant sterols include, for example, brassicasterol, isofucosterol, stigmasterol, 7-stigmastenol, -sitosterol, ⁇ -sitosterol, campesterol, brassicastanol, isofcostanol, stigmasteranol, 7-stigma
- Examples include free forms such as stanol, ⁇ -sitostanol, 13-sitostanol, campestanol, cycloartenol, cholesterol, and avenasterol, and ester forms such as fatty acid esters, ferulic acid esters, and cinnamic acid esters.
- brass castellonoles, campesteronoles, stigmastellonoles, ⁇ -sitosterol strength are preferred in terms of industrial productivity and flavor.
- the total content of brassicasterol, campesterol, stigmasterol, and / 3-sitosterol in the plant sterols (C) is preferably 90% or more.
- LOO%, particularly 94-99% is preferable in terms of flavor, appearance, industrial production of fats and oils, crystal precipitation, storage at low temperature, and physiological effects.
- the content of brassicasterol in the plant sterols (C) is preferably 0.5 to 8%, more preferably 1 to 7.5%, particularly 3 to 7%. In view of appearance, industrial productivity of fats and oils, crystal precipitation, storage at low temperature, and physiological effects.
- the content of campesterol in the plant sterols (C) is preferably 10 to 40%, and more preferably 15 to 35%, especially 22 to 30%. It is preferable in terms of productivity, crystal precipitation, storage at low temperature, and physiological effects.
- the content of stigmasterol in the plant sterols (C) is preferably 3 to 30%, and more preferably 5 to 25%, especially 7 to 15%. From the viewpoints of productivity, crystal precipitation, storage at low temperature, and physiological effects.
- the content of 13-sitosterol in the plant sterols (C) is preferably 30 to 60%, and more preferably 35 to 58%, particularly 40 to 56%. From the viewpoints of productivity, crystal precipitation, storage at low temperature, and physiological effects.
- the content of cholesterol in the plant sterols (C) is preferably 1% or less, more preferably 0.01 to 0.8%, particularly 0.1 to 0.7%, and particularly 0. Power of 2 to 0.6% is preferred in terms of blood cholesterol lowering, industrial productivity of fats and oils.
- the content of unsaturated fatty acids among the constituent fatty acids is 80% or more.
- S preferably 85 to: LOO%, especially 86 to 98%, especially 88 to 93% S, flavor, appearance, storage at low temperature, crystal precipitation, industrial production of fats and oils, oxidation stability From the viewpoint of the physiological effect.
- the weight ratio (CLAZPS) of the CLA content in DAG and the content of plant sterols (hereinafter also simply referred to as “PS”) in fats and oils is preferably less than 700. More preferably, it is 1 to 400, more preferably 5 to 250, more preferably 10 to 100, and especially 15 to 70, which is preferable in terms of storage stability at low temperatures. This is more preferably applied when the weight ratio of 1,3-DAG / l, 2-DAG in the fat is 1.5 to 3.8, and further 2 to 3.5, especially 2.1. ⁇ 3.2 is preferred in terms of storage stability at low temperatures, physiological effects, and industrial productivity of fats and oils.
- PSE plant sterol fatty acid ester
- the oil and fat composition preferably further contains a crystallization inhibitor (D).
- the crystal inhibitor include polyglycerin condensed ricinoleic acid ester, polyglycerin fatty acid ester, sucrose fatty acid ester, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, propylene glycol fatty acid ester and the like.
- Polyglycerin fatty acid ester, sucrose fatty acid ester, and sorbitan fatty acid ester are preferred, and polyglycerin fatty acid ester is particularly preferred.
- the HLB value of the polyol fatty acid ester is 4 or less, particularly 0.1 to 3.5 calculated by Griffin's formula (J. Soc. Cosmet. Chem., 1, 311 (1949)). It is preferable.
- the content of unsaturated fatty acid among the fatty acids constituting the polyglycerin fatty acid ester is 50 to 95. Further, it is preferably 51 to 80%, and more preferably 52 to 60%, from the viewpoints of crystallization suppression, solubility in fats and oils, and acid / acid stability. Further, from the viewpoint of facilitating dissolution of the polyglycerin fatty acid ester in fats and oils, the content of unsaturated fatty acid is preferably 50% or more.
- the content of unsaturated fatty acids is preferably 95% or less.
- the unsaturated fatty acid constituting the polyglycerin fatty acid ester preferably has 10 to 24 carbon atoms, more preferably 16 to 22 carbon atoms. Specific examples include palmitoleic acid, oleic acid, petrothelic acid, elaidic acid, linoleic acid, linolenic acid, gatrenic acid, erucic acid, and the like, with oleic acid, linoleic acid and gatrenic acid being preferred.
- the content of oleic acid is preferably 80% or more, more preferably 90-99.8%, crystal suppression, oil solubility, cost, It is preferable in terms of oxidation stability and flavor.
- the content of linoleic acid is preferably 10% or less, and more preferably 0.1 to 5%, crystal suppression, solubility in fats and oils, cost, It is preferable in terms of oxidation stability and flavor.
- the content of gatrenic acid is preferably 10% or less, and particularly 0.1 to 5% is crystal suppression, solubility in fats and oils, cost, It is preferable in terms of oxidation stability and flavor.
- the content of saturated fatty acid among the fatty acids constituting the polyglycerin fatty acid ester is 5 to 50. Further, it is preferably 20% to 49%, and particularly preferably 40% to 48%, from the viewpoints of crystal suppression, solubility in fats and oils, and acidity stability.
- This saturation The number of carbon atoms of the fatty acid is preferably 10-24, more preferably 12-22.
- the saturated fatty acids constituting the polyglycerin fatty acid ester include lauric acid, myristic acid, palmitic acid, stearic acid, arachidic acid, and behenic acid, and myristic acid, palmitic acid, and stearic acid are preferable.
- the content of palmitic acid is preferably 80% or more, particularly 90 to 99.8%, which suppresses crystallization, solubility in fats and oils, cost, It is preferable in terms of oxidation stability and flavor.
- the content of myristic acid in the constituent saturated fatty acid of polyglycerin fatty acid ester is preferably 10% or less, especially 0.1-5%, crystal suppression, solubility in fats and oils, cost, oxidation stability It is preferable in terms of properties and flavor.
- the content of stearic acid in the saturated fatty acid of the polyglycerin fatty acid ester is preferably 10% or less, and particularly 0.1 to 5% is crystal suppression, solubility in fats and oils, cost, oxidation stability It is preferable in terms of sex and flavor.
- the content of the crystallization inhibitor (D) is 0.01 to 2 parts, more preferably 0.02 to 0.5 parts, and particularly preferably 0.05 to 100 parts of the fat (A). It is preferable that it is -0.2 part from the point of the solubility to fats and oils, cost, flavor, and crystal
- the oil and fat composition preferably further contains an organic carboxylic acid having 2 to 8 carbon atoms and Z or a salt thereof.
- organic carboxylic acid having 2 to 8 carbon atoms is
- citrate is preferred.
- the oil and fat composition is prepared by selecting the raw oil and fat and the production method so that the component (A) of the composition has a predetermined ratio, and adding the component (B) thereto, Ingredients as needed (
- component (D) component (D), antioxidant, organic carboxylic acid and Z or a salt thereof are added and heated appropriately.
- the oil and fat composition of the present invention is excellent in terms of storage stability, flavor, texture, appearance, work comfort during cooking, physiological effects, and the like, and can be applied to various foods.
- oils and fats that contain the oil and fat composition as part of the food.
- powerful oils and fats processed foods include health foods, functional foods, foods for specified health use, etc. that promote specific health by promoting specific functions.
- the Specific products include bakery foods such as bread, cakes, biscuits, pies, pizza crusts, bakery mixes, oil-in-water emulsions such as soups, sauces, dressings, mayonnaise, coffee whiteners, ice creams, whipped creams, Water-in-oil emulsions such as margarine, spreads and butter cream, snacks such as potato chips, confectionery such as chocolate, caramel, candy and dessert, processed foods such as ham, sausage and hamburger, milk, cheese and yogurt And dairy products such as dough, enrober fats and oils, filling fats and oils, koji, frozen foods, retort foods, beverages and roux.
- bakery foods such as bread, cakes, biscuits, pies, pizza crusts
- bakery mixes oil-in-water emulsions such as soups, sauces, dressings, mayonnaise, coffee whiteners, ice creams, whipped creams, Water-in-oil emulsions such as margarine, spreads and butter cream
- snacks such
- oil and fat composition of the present invention In addition to the oil and fat composition of the present invention, food materials generally used can be added and produced according to the type of processed oil and fat food.
- the blending amount of the oil and fat composition of the present invention in food varies depending on the type of food, but is generally 0.1 to 100%, particularly preferably 1 to 80%.
- the oil and fat composition of the present invention can be used as a food ingredient such as cooking oil used for fried foods or fried foods.
- cooking oil used for fried foods or fried foods In particular, croquettes, tempura, tonkatsu, fried fish, fried fish, spring rolls, etc. Suitable for cooking instant rice cakes.
- the weight ratio of the oil and fat derived from the food material and the oil and fat composition of the present invention is as follows. Fats and oils derived from food materials Z
- the oil and fat composition of the present invention is preferably 95Z5 to 1Z99, more preferably 95/5 to 5/95, particularly 85/15 to 5/95, especially 40/60 to 5/95. Being force S is preferable.
- the oil and fat composition of the present invention can be used for an oil-in-water emulsion.
- the weight ratio between the oil phase and the aqueous phase is preferably 1Z99 to 90Z10 for the oil phase Z and the water phase, more preferably 10 to 90 to 20, more preferably 30 to 70 to 75.
- emulsifiers include egg protein, soybean protein, milk protein, proteins separated from these proteins, various proteins such as (partial) degradation products of these proteins, sucrose fatty acid ester, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid.
- Ester Daricelin fatty acid monoester, Polyglycerin fatty acid ester, Polyglycerin condensed ricinole Examples thereof include inic acid esters, glycerin organic acid fatty acid esters, propylene glycol fatty acid esters, lecithin, and enzymatic degradation products thereof.
- the oil or fat composition of the present invention is used in an oil-in-water emulsion, it is preferable to contain 0 to 5%, particularly 0.01 to 2% of a stabilizer.
- Stabilizers include thickening polysaccharides such as xanthan gum, dielan gum, guar gum, carrageenan, pectin, tragacanth gum, konjac mannan, starch, and the like.
- flavoring agents such as salt, sugar, vinegar, fruit juice, seasoning, flavoring agents such as snow and flavor, coloring agents, preservatives, antioxidants, etc. can be used as appropriate. .
- oil-in-water type oil-containing foods such as mayonnaise, dressing, coffee whitener, ice cream, whipped cream, beverages, etc. can be produced by conventional methods.
- the oil and fat composition of the present invention can be used for a water-in-oil emulsion.
- the weight ratio of the water phase to the oil phase is preferably 85Z15 to 1Z99 for the water phase Z oil phase, more preferably 80Z20 to LOZ 90, and particularly preferably 70Z30 to 35Z65.
- emulsifiers include egg protein, soybean protein, milk protein, proteins separated from these proteins, various proteins such as (partial) degradation products of these proteins, sucrose fatty acid ester, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid.
- examples include esters, daridine fatty acid monoesters, polyglycerin fatty acid esters, polyglycerin condensed ricinoleic acid esters, glycerin organic acid fatty acid esters, propylene glycol fatty acid esters, lecithin, and enzymatic degradation products thereof.
- flavors such as salt, sugar, vinegar, fruit juice, seasonings, flavorings such as spices and flavors, stabilizers such as thickening polysaccharides and starches, coloring agents, preservatives, etc.
- stabilizers such as thickening polysaccharides and starches, coloring agents, preservatives, etc.
- Antioxidants and the like can be used.
- water-in-oil type oil-containing foods such as margarine, spreads, butter cream and the like can be prepared by a conventional method.
- the oil and fat composition of the present invention has a body fat accumulation inhibitory action, a visceral fat accumulation inhibitory action, a body weight gain inhibitory action, a serum triglyceride increase inhibitory action, an insulin resistance improving action, a blood sugar level rise inhibitory action, a sputum index Has excellent physiological activities such as an improving action and an antifeedant action. Because of having excellent characteristics, the oil and fat composition of the present invention is a food for specified health use, sick It can be used for foods for health use, health function appealing foods, and pharmaceuticals.
- the oil and fat composition of the present invention can be used for pharmaceuticals in the form of capsules, tablets, granules, powders, liquids, gels and the like.
- a pharmaceutical in addition to the above-described oil and fat composition, excipients, disintegrants, binders, lubricants, surfactants, alcohols, water, water-soluble polymers, sweeteners, corrigents that are generally used depending on the form. Additives, acidulants, etc. can be added.
- the amount of the oil / fat composition of the present invention to be added to a pharmaceutical product is generally 0.1 to 80%, more preferably 0.2 to 50%, and particularly preferably 0.5 to 30% depending on the use and form of the pharmaceutical product. It is preferable.
- the dosage is preferably 0.2 to 50 g per day as an oil / fat composition divided into 1 to several times.
- the administration period is preferably 1 month or more, 2 months or more, and 3 to 12 months.
- the oil and fat composition of the present invention can be used for feed.
- feed examples include livestock feed for cattle, pigs, chickens, sheep, horses, goats, etc., feed for small animals for rabbits, rats, mice, etc., and seafood for eels, Thailand, hamachi, shrimp, etc.
- the blending amount of the oil and fat composition of the present invention into the feed is generally 1 to 30%, particularly preferably 1 to 20%, which varies depending on the use of the feed. The combination is performed by replacing all or part of the fat and oil in the feed with the fat and oil composition of the present invention.
- feed is mixed with feed ingredients generally used such as meat, protein, cereals, bran, potatoes, sugars, vegetables, vitamins, and minerals as needed. Manufactured.
- Examples of meat include cattle, pigs, sheep (mutton or lamb), rabbits, kangaroos and other livestock meat, beef and its by-products, processed products (rendered products of the above ingredients such as meatballs, meatbone meal, chicken meal) , Fish and shellfish such as tuna, bonito, horse mackerel, sardines, scallops, scallops, and fish meal.
- Examples of the protein include milk proteins such as casein and whey, animal proteins such as egg protein, and plant proteins such as soybean protein.
- Examples of cereals include wheat, barley, rye, my mouth, and corn.
- Examples of the strength include rice bran and bran.
- Examples of potatoes include soybean meal. The total amount of meat, protein, grains, bran and potatoes in the feed is 5-9 3. 9% is preferred.
- saccharide examples include glucose, oligosaccharide, sugar, molasses, starch, liquid sugar and the like, and preferably 5 to 80% in feed.
- examples of vegetables include vegetable extracts and the like, and it is preferable to contain 1 to 30% in the feed.
- vitamins include A, B, B, D, E, niacin, pantothenic acid, carotene and the like.
- % Content is preferable.
- minerals include calcium, phosphorus and sodium
- Potassium, iron, magnesium, zinc and the like, and 0.05 to 10% in feed is preferable.
- gelling agents, shape-preserving agents, pH adjusters, seasonings, preservatives, nutritional supplements and the like that are generally used in feeds can be contained as necessary.
- reaction product (TAG41. 8%, DAG36. 8%, MAGI. 2%, FFA20. 2%) was subjected to silica gel column chromatography (Wako C-200, It was packed in Wako Pure Chemical Industries, Ltd.
- fat E was obtained by adding 0.02 parts of Tocopherol (Mixed Tocopherol MDE-6000, manufactured by Yatsushiro) to 100 parts of fat obtained by mixing each fraction.
- Table 1 shows the glyceride yarn composition and fatty acid composition.
- Tocopherol (Mixtocopherol MDE-6000, manufactured by Yatsushiro) 0.02 parts, plant sterol fatty acid ester (CardioAid- S, ADM) for 100 parts of fat and oil E mixed with rapeseed oil in a weight ratio of 1: 2 4 parts) was added to obtain fat F.
- Table 1 shows the glyceride composition and fatty acid composition of fat F.
- the fatty acid composition of rapeseed oil is shown in Table 1 footnote (* 2).
- oil G was added with 0.3 part of plant sterol (phytosterol F, manufactured by Tama Seikagaku), and oil H was obtained with 4 parts.
- Fat A and Fat G are mixed in a weight ratio of 7: 3, 5: 5, 3: 7, and Fats I, Fats J, Fats are mixed.
- fats and oils A and fats and oils H are mixed in a weight ratio of 7: 3, 5: 5, and 3: 7.
- Oil M and oil N Oil M and oil N.
- Rapeseed oil, fat A and fat G were mixed at a weight ratio of 50:25:25 to prepare fat O. Also
- Rapeseed oil, fat A and fat H were mixed at a weight ratio of 50:25:25 to prepare fat P.
- fat P Rapeseed oil, fat A and fat H were mixed at a weight ratio of 50:25:25 to prepare fat P.
- the rapeseed oil is the same as that used in the above fat F.
- sample 10 mg and trimethylsilylating agent (silylating agent TH", manufactured by Kanto Chemical Co., Ltd.) 0.5 mL were placed, sealed, and heated at 70 ° C for 15 minutes. After adding ImL of water, add 2mL of hexane and shake well. After standing, the hexane phase was extracted and subjected to gas chromatography (GLC) for analysis.
- silating agent TH trimethylsilylating agent
- Methyl esterified fatty acid was subjected to analysis by GLC.
- Fat E and rapeseed oil * 2 are mixed at a weight ratio of 1: 2.
- a storage test was conducted by using the fats and oils A and B by the following method.
- a glass sample bottle 50 mL was charged with 20 g of oil and fat, sealed with nitrogen, and sealed. This was stored in a freezer at 20 ° C. Five years later, the sample was allowed to stand at room temperature, thawed, opened, and subjected to sensory evaluation of odor and appearance according to the following criteria. The results are shown in Table 2.
- b Deteriorated odor is slightly felt, but chemical odor is slightly good.
- c Deteriorated odor and chemical odor.
- the gel-like portion occupies the majority and is defective.
- the product of the present invention was shown to have better odor and appearance and better storage than the comparative product.
- feed was produced according to a conventional method. Six to seven week old Zucker rats were divided into 4 groups of 6 animals per group. First, the animals were preliminarily raised with feed 1 for 4 days (constant food intake). Each feed was then bred for 9 days. The amount of food intake at this time was measured every day. On the last day of the administration of the feed, dissection was performed, and the liver, perirenal adipose tissue, and adipose testicle adipose tissue were removed and their weights were measured. In addition, the amount of triglyceride in the liver was measured. The results are shown in Table 4.
- Feed composition (parts by weight) Feed 1 Feed 2 Feed 3 Feed 4 Casein 20 20 20 20 Cellulose 4 4 4 4 Mineral mixture 3.5 3.5 3.5 3.5 Vitamin mixture 1 1 1 1 1 Potato starch 61.5 57.5 57.5 57.5 Oil * 3 WXYZ Corn oil * 4 10 10 10 Oil A 0 4 0 0
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Edible Oils And Fats (AREA)
- Fats And Perfumes (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2006/315925 WO2008018147A1 (en) | 2006-08-11 | 2006-08-11 | Fat or oil composition |
CN2006800555988A CN101505609B (zh) | 2006-08-11 | 2006-08-11 | 油脂组合物 |
JP2008528705A JP5155863B2 (ja) | 2006-08-11 | 2006-08-11 | 油脂組成物 |
KR1020097002512A KR101297921B1 (ko) | 2006-08-11 | 2006-08-11 | 유지 조성물 |
US12/376,440 US8853192B2 (en) | 2006-08-11 | 2006-08-11 | Fat or oil composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2006/315925 WO2008018147A1 (en) | 2006-08-11 | 2006-08-11 | Fat or oil composition |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008018147A1 true WO2008018147A1 (en) | 2008-02-14 |
Family
ID=39032692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2006/315925 WO2008018147A1 (en) | 2006-08-11 | 2006-08-11 | Fat or oil composition |
Country Status (5)
Country | Link |
---|---|
US (1) | US8853192B2 (ja) |
JP (1) | JP5155863B2 (ja) |
KR (1) | KR101297921B1 (ja) |
CN (1) | CN101505609B (ja) |
WO (1) | WO2008018147A1 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1917230A1 (en) * | 2005-08-02 | 2008-05-07 | Keele University | Glyceride compounds and uses thereof |
JP2010119329A (ja) * | 2008-11-19 | 2010-06-03 | Kao Corp | ペットフード |
JP2010227004A (ja) * | 2009-03-27 | 2010-10-14 | Nof Corp | 水中油型食用乳化組成物 |
WO2011075802A1 (en) | 2009-12-24 | 2011-06-30 | Companhia Refinadora Da Amazônia | Production of diacylglycerols by lipase - catalyzed hydrolysis of palm oil |
WO2014038545A1 (ja) * | 2012-09-04 | 2014-03-13 | 花王株式会社 | 油脂組成物 |
EP3305083A1 (en) * | 2008-04-21 | 2018-04-11 | Asha Nutrition Sciences, Inc. | Lipid-containing compositions and methods of use thereof |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2012DN05212A (ja) | 2009-12-15 | 2015-10-23 | Kao Corp | |
JP5706094B2 (ja) * | 2010-03-31 | 2015-04-22 | 花王株式会社 | 油脂組成物 |
EP2578087B1 (en) * | 2010-05-25 | 2014-12-03 | Kao Corporation | Pet food |
JP5872380B2 (ja) | 2011-05-20 | 2016-03-01 | 花王株式会社 | 油脂組成物 |
BR102014012953A2 (pt) | 2014-05-29 | 2018-04-17 | Universidade Estadual De Campinas - Unicamp | Processo de obtenção de composições estruturadas de gorduras, composições estruturadas assim obtidas e seus usos |
JP6797269B2 (ja) | 2018-11-20 | 2020-12-09 | 花王株式会社 | 油脂組成物 |
CN110141564A (zh) * | 2019-06-06 | 2019-08-20 | 广东省农业科学院蚕业与农产品加工研究所 | 一种富含多不饱和脂肪酸的甘油酯混合物及其制备方法和应用 |
CN111040875A (zh) * | 2020-01-06 | 2020-04-21 | 武汉轻工大学 | 一种抗氧化剂及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002322490A (ja) * | 2001-04-26 | 2002-11-08 | Kao Corp | 油脂組成物 |
JP2006513307A (ja) * | 2003-04-25 | 2006-04-20 | イルシンウェルズ コーポレーション リミティッド | 共役リノール酸を含む高純度ジグリセリド油脂組成物及びその製造方法 |
JP2006137923A (ja) * | 2004-04-28 | 2006-06-01 | Kao Corp | 油脂組成物 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3098560B2 (ja) | 1991-03-28 | 2000-10-16 | 花王株式会社 | 体重増加抑制剤 |
US5554646A (en) | 1992-04-29 | 1996-09-10 | Wisconsin Alumni Research Foundation | Method for reducing body fat in animals |
ES2133655T3 (es) | 1994-03-31 | 1999-09-16 | Unilever Nv | Aceites con bajo contenido de acidos grasos saturados. |
US5814663A (en) | 1994-08-29 | 1998-09-29 | Wisconsin Alumni Research Foundation | Method for maintaining an existing level of body fat |
JP3569116B2 (ja) | 1996-10-18 | 2004-09-22 | 花王株式会社 | 液状汎用型油脂組成物 |
US6004611A (en) * | 1996-10-18 | 1999-12-21 | Kao Corporation | General-purpose oils composition |
US6025348A (en) * | 1998-04-30 | 2000-02-15 | Kao Corporation | Oil and fat composition containing phytosterol |
DK0990391T3 (da) * | 1998-03-24 | 2009-06-08 | Kao Corp | Phytosterolholdig fedtsammensætning |
US6139897A (en) * | 1998-03-24 | 2000-10-31 | Kao Corporation | Oil or fat composition containing phytosterol |
US20050013907A1 (en) * | 1998-10-12 | 2005-01-20 | Compagnie Gervais Danone | Food composition based on a substance derived from milk comprising conjugate linoleic acid glycerides |
FR2784268B1 (fr) | 1998-10-12 | 2000-12-29 | Gervais Danone Sa | Nouvelle composition alimentaire, a base de matiere issue du lait, sous la forme d'une emulsion huile dans eau |
WO2000064854A1 (fr) | 1999-04-27 | 2000-11-02 | Kabushiki Kaisha Yakult Honsha | Esters d'acides gras conjugues |
JP4098927B2 (ja) | 1999-08-03 | 2008-06-11 | 花王株式会社 | 油脂組成物 |
US6762203B2 (en) * | 1999-08-03 | 2004-07-13 | Kao Corporation | Oil composition |
EP1097708B1 (en) | 1999-11-02 | 2003-09-17 | Loders Croklaan B.V. | Use of trans-trans isomers of conjugated linoleic acid |
US6225910B1 (en) * | 1999-12-08 | 2001-05-01 | Gentex Corporation | Smoke detector |
AU2000265105A1 (en) | 2000-08-02 | 2002-02-13 | Pharmanutrients | Methods and compositions for the prevention and treatment of syndrome x |
JP2004505042A (ja) | 2000-08-02 | 2004-02-19 | ファーマニュートリエンツ | 糖尿病及びグルコース変性の予防及び/または治療のための方法及び組成物 |
DE60143753D1 (de) | 2000-08-08 | 2011-02-10 | Kao Corp | Öl-/fett-zusammensetzung |
AU2001236616A1 (en) | 2000-08-26 | 2002-03-13 | Metagenics, Inc. | Improved stability conjugated linoleic acid composition for dietary supplement and food uses |
WO2002041706A2 (en) | 2000-11-21 | 2002-05-30 | Alpha Foods Ingredients, Inc. | Bioactive compositions comprising conjugated linoleic acid glycerides and methods for producing bioactive conjugated linoleic acid |
JP2002194387A (ja) | 2000-12-27 | 2002-07-10 | Kanegafuchi Chem Ind Co Ltd | 油脂の安定化方法 |
JP2002265374A (ja) * | 2001-03-06 | 2002-09-18 | Taiyo Kagaku Co Ltd | 体脂肪減少用組成物 |
JP3970669B2 (ja) | 2001-08-02 | 2007-09-05 | 日清オイリオグループ株式会社 | 共役脂肪酸含有モノグリセリドおよびその製造方法 |
JP4116844B2 (ja) * | 2001-09-13 | 2008-07-09 | 花王株式会社 | 油脂組成物 |
JP2003171272A (ja) | 2001-12-07 | 2003-06-17 | Rinoru Oil Mills Co Ltd | 10トランス,12シス−共役リノール酸を有効成分とする抗腫瘍剤 |
JP2007512407A (ja) | 2003-11-28 | 2007-05-17 | オンビオ コーポレーション | 共役リノール酸のジグリセライドの豊富な油脂組成物 |
US20080069932A1 (en) * | 2004-04-28 | 2008-03-20 | Kao Corporation | Oil or Fat Composition |
DE102004043824A1 (de) * | 2004-09-10 | 2006-03-16 | Cognis Ip Management Gmbh | Emulsionen mit ungesättigten Fettsäuren und deren Estern |
-
2006
- 2006-08-11 KR KR1020097002512A patent/KR101297921B1/ko not_active IP Right Cessation
- 2006-08-11 CN CN2006800555988A patent/CN101505609B/zh not_active Expired - Fee Related
- 2006-08-11 WO PCT/JP2006/315925 patent/WO2008018147A1/ja active Application Filing
- 2006-08-11 JP JP2008528705A patent/JP5155863B2/ja not_active Expired - Fee Related
- 2006-08-11 US US12/376,440 patent/US8853192B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002322490A (ja) * | 2001-04-26 | 2002-11-08 | Kao Corp | 油脂組成物 |
JP2006513307A (ja) * | 2003-04-25 | 2006-04-20 | イルシンウェルズ コーポレーション リミティッド | 共役リノール酸を含む高純度ジグリセリド油脂組成物及びその製造方法 |
JP2006137923A (ja) * | 2004-04-28 | 2006-06-01 | Kao Corp | 油脂組成物 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1917230A1 (en) * | 2005-08-02 | 2008-05-07 | Keele University | Glyceride compounds and uses thereof |
EP3305083A1 (en) * | 2008-04-21 | 2018-04-11 | Asha Nutrition Sciences, Inc. | Lipid-containing compositions and methods of use thereof |
JP2018064563A (ja) * | 2008-04-21 | 2018-04-26 | アーシャ ニュートリション サイエンシーズ, インコーポレイテッド | 脂質含有組成物およびその使用方法 |
JP2010119329A (ja) * | 2008-11-19 | 2010-06-03 | Kao Corp | ペットフード |
JP2010227004A (ja) * | 2009-03-27 | 2010-10-14 | Nof Corp | 水中油型食用乳化組成物 |
WO2011075802A1 (en) | 2009-12-24 | 2011-06-30 | Companhia Refinadora Da Amazônia | Production of diacylglycerols by lipase - catalyzed hydrolysis of palm oil |
WO2014038545A1 (ja) * | 2012-09-04 | 2014-03-13 | 花王株式会社 | 油脂組成物 |
Also Published As
Publication number | Publication date |
---|---|
JP5155863B2 (ja) | 2013-03-06 |
US20100267681A1 (en) | 2010-10-21 |
CN101505609B (zh) | 2013-07-17 |
KR101297921B1 (ko) | 2013-08-19 |
CN101505609A (zh) | 2009-08-12 |
US8853192B2 (en) | 2014-10-07 |
KR20090037927A (ko) | 2009-04-16 |
JPWO2008018147A1 (ja) | 2009-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5155863B2 (ja) | 油脂組成物 | |
JP5636398B2 (ja) | 油脂組成物 | |
JP4381037B2 (ja) | 油脂組成物 | |
JP5100974B2 (ja) | 油脂組成物 | |
EP1544281B1 (en) | Fat composition | |
US7410663B2 (en) | Oil or fat composition | |
WO2006088188A1 (ja) | 油脂組成物 | |
WO2002011550A2 (en) | Oil/fat composition | |
EP1424907A1 (en) | Oil composition | |
WO2005052102A1 (en) | A composition enriched in diglyceride with conjugated linoleic acid | |
JP5039291B2 (ja) | 油脂組成物 | |
JP4268473B2 (ja) | 油脂組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680055598.8 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06796363 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008528705 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12376440 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020097002512 Country of ref document: KR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06796363 Country of ref document: EP Kind code of ref document: A1 |